Correspondence on: ?SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy'

被引：3
|
作者：
Soler, Maria Jose [1 ,2 ,4 ]
Cacha, Conxita Jacobs [1 ,2 ]
Anders, Hans-Joachim [3 ]
机构：
[1] Univ Autonoma Barcelona, Hosp Univ Vall Dhebron, Nephrol Dept, Barcelona, Spain
[2] Vall Dhebron Res Inst VHIR, Nephrol Res Grp, Barcelona, Spain
[3] Univ Munich, Nephrol Ctr, Med Clin & Policlin 4, Munich, Germany
[4] Vall Dhebron Univ Hosp, Nephrol, Barcelona, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年 / 83卷 / 06期
关键词：
Lupus Nephritis; Lupus Erythematosus; Systemic; Autoimmune Diseases;
D O I：
10.1136/ard-2023-225248
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e13 / e13
页数：1
相关论文
共 40 条
  • [1] Response to: Correspondence on ?SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
    Qi, Yuan-yuan
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (06)
  • [2] SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
    Zhao, Xin-yu
    Li, Shuang-shuang
    He, Ying-xin
    Yan, Li-jie
    Lv, Fu
    Liang, Qi-meng
    Gan, Yu-hui
    Han, Li-pei
    Xu, Hong-de
    Li, Yong-chun
    Qi, Yuan-yuan
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10) : 1328 - 1340
  • [3] SGLT2 inhibitors protect podocytes in lupus nephritis
    Sarah Onuora
    Nature Reviews Rheumatology, 2023, 19 : 605 - 605
  • [4] SGLT2 inhibitors protect podocytes in lupus nephritis
    Onuora, Sarah
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (10) : 605 - 605
  • [5] Demethylzeylasteral ameliorates podocyte damage in murine lupus by inhibiting inflammation and enhancing autophagy
    Shen, Pan
    Deng, Xuan
    Chen, Zhe
    Chen, Min
    Han, Liang
    Chen, Xiaoqi
    Tu, Shenghao
    PHYTOMEDICINE, 2024, 134
  • [6] SGLT2 inhibitors and autophagy in diabetes
    Yaribeygi, Habib
    Maleki, Mina
    Atkin, Stephen L.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    CELL BIOCHEMISTRY AND FUNCTION, 2023, 41 (04) : 392 - 398
  • [7] Beyond glucose control: SGLT2 inhibitors' impact on hematological parameters in lupus nephritis patients
    Mohamed, Nourelsabah
    Refaie, Ayman F.
    Zayed, Karem N.
    Mortada, Wael I.
    Nabieh, Kareem A.
    Sobh, Mohamed A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I657 - I657
  • [8] Beyond glucose control: SGLT2 inhibitors' impact on hematological parameters in lupus nephritis patients
    Mohamed, Nourelsabah
    Refaie, Ayman F.
    Zayed, Karem N.
    Mortada, Wael, I
    Nabieh, Kareem A.
    Sobh, Mohamed A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [9] SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy
    Cassis, Paola
    Locatelli, Monica
    Cerullo, Domenico
    Corna, Daniela
    Buelli, Simona
    Zanchi, Cristina
    Villa, Sebastian
    Morigi, Marina
    Remuzzi, Giuseppe
    Benigni, Ariela
    Zoja, Carlamaria
    JCI INSIGHT, 2018, 3 (15):
  • [10] SGLT2 Inhibition in Nondiabetic CKD: Results in Experimental Lupus Nephritis (LN)
    Vilardell, Jordi
    Jacobs Cacha, Conxita
    Martos, Nerea
    Llorens Cebria, Carmen
    Motto, Aku Enam
    Lech, Maciej
    Martinez Diaz, Irene
    Anders, Hans J.
    Soler, Maria Jose
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
1234